Manasmita Das

Manasmita Das

Auto-generated profile, based on publicly available information

Manasmita Das

National Institute of Pharmaceutical Education and Research (NIPER)

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2011 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
HHHarshad Harde
Harshad Harde
MDManasmita Das
Manasmita Das
SJSanyog Jain
Sanyog Jain
Introduction: The therapeutic efficacy of perorally administered drugs is often obscured by their poor oral bioavailability (BA) and low metabolic stability in the gastrointestinal tract (GIT). Solid lipid nanoparticles (SLNs) have emerged as potential BA enhancer vehicles for various Class II, III and IV drug molecules. Area covered: This review examines the recent advancements in SLN technology, with regards to oral drug delivery. The discussion critically examines the effect of various key constituents on SLN absorption and their applications in oral drug delivery. The relationship between the complexity of absorption (and various factors involved during absorption, including particle size), stability and the self-emulsifying ability of the lipids used has been explored. Expert opinion: The protective effect of SLNs, coupled with their sustained/controlled release properties, prevents drugs/macromolecules from premature degradation and improves their stability in the GIT. An extensive literature survey...

14 December 2009 in Small
Verified
Journal Article
Closed access
PDF file
MDManasmita Das
Manasmita Das
DMDebasish Mishra
Debasish Mishra
PDPrasanta Dhak
Prasanta Dhak
SGSatyajit Gupta
Satyajit Gupta
TMTapas Kumar Maiti
Tapas Kumar Maiti
PPPanchanan Pramanik
Panchanan Pramanik

6 October 2011 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
SJSanyog Jain
Sanyog Jain
VTVivek S. Thakare
Vivek S. Thakare
MDManasmita Das
Manasmita Das
Chandraiah GoduguChandraiah Godugu
Chandraiah Godugu
AJAmit K. Jain
Amit K. Jain
AMAnil K. Mishra
Anil K. Mishra

20 September 2012 in Nanomedicine
Verified
Journal Article
Closed access
SJSanyog Jain
Sanyog Jain
VRVishal V Rathi
Vishal V Rathi
AJAmit K Jain
Amit K Jain
MDManasmita Das
Manasmita Das
Chandraiah GoduguChandraiah Godugu
Chandraiah Godugu
The present study reports a novel approach for enhancing the oral absorption and hypoglycemic activity of insulin via encapsulation in folate-(FA) coupled polyethylene glycol (PEG)ylated polylactide-co-glycolide (PLGA) nanoparticles (NPs; FA-PEG-PLGA NPs). Insulin-loaded FA-PEG-PLGA NPs (size ∼260 nm; insulin loading ∼6.5% [w/w]; encapsulation efficiency: 87.0 ± 1.92%) were prepared by double-emulsion solvent evaporation method. The bioavailability and hypoglycemic activity of orally administered FA-insulin NPs were studied in diabetic rats. FA-PEG-PLGA NPs (50 U/kg) exhibited a twofold increase in the oral bioavailability (double hypoglycemia) without any hypoglycemic shock as compared to subcutaneously administered standard insulin solution. Insulin NPs maintained a continual blood glucose level for 24 h, which, however, was transient (<8 h) in the case of subcutaneous insulin and associated with severe hypoglycemic shock. Overall, we have developed a patient-compliant, oral nanoformulation of insulin, once-daily administration of which would be sufficient to control diabetes for at least 24 h.

1 October 2011 in Biomaterials
Verified
Journal Article
Closed access
NSNitin K. Swarnakar
Nitin K. Swarnakar
AJAmit K. Jain
Amit K. Jain
RSRaman Singh
Raman Singh
Chandraiah GoduguChandraiah Godugu
Chandraiah Godugu
MDManasmita Das
Manasmita Das
SJSanyog Jain
Sanyog Jain

17 October 2012 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
Satyajit DatirSatyajit Datir
Satyajit Datir
MDManasmita Das
Manasmita Das
RSRaman Singh
Raman Singh
SJSanyog Jain
Sanyog Jain